Xuefeng Huang

Mr. Xuefeng Huang

Fuguikang (Tianjin) Pharmaceutical Technology Co., Ltd., Tianjin, China
orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 August 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
Xuefeng HuangXuefeng Huang
Xuefeng Huang
The investing fascia is the most superficial layer of the deep cervical fascia, forming a continuous fibrous sleeve that encircles the entire neck and contributes to the formation of the carotid sheath. This article proposes an as-yet-unverified integrative biomechanical hypothesis, positing that chronic static postural loading may induce fibrotic remodeling of the investing fascia. Following the loss of local elastic buffering capacity, residual passive tension may, in theory, be transmitted across layers through the collagen fiber network of the three-layer deep cervical fascia (investing layer → pretracheal layer → prevertebral layer)—although the efficiency of this transmission awaits direct experimental verification via ex vivo mechanical testing. Should such transmission occur, it may, through PIEZO1/2-mediated mechanotransduction (the expression and function of these channels in this fascia remain to be validated by immunohistochemistry), influence fibroblast activity and nerve terminal excitability, potentially inducing secondary fibrosis in the middle layer (carotid sheath) and deep layer (prevertebral fascia). Through five downstream pathways—arterial compression potentially leading to cerebral and ocular hypoperfusion; venous compression potentially associated with intracranial hypertension and elevated intraocular pressure; impaired lymphatic drainage potentially linked to ocular fluid retention; sympathetic nerve stimulation potentially contributing to vasoconstriction and intraocular pressure fluctuations; and vagus nerve compression potentially associated with autonomic imbalance—this cascade may constitute a long-overlooked potential mechanical node underlying cerebral hypoperfusion and a range of ocular disorders. The hypothesis proposes five testable predictions and outlines a three-tiered validation framework comprising immunohistochemistry, fluid-structure interaction finite element simulation, and a prospective human mechanistic validation cohort. This hypothesis attempts to extend the Sirtuins-mediated fibrosis regulatory checkpoints proposed by Zullo et al. and the fascial mechanotransmission framework established by Schleip et al. into the domain of brain-eye comorbidities, providing a testable biomechanical framework for understanding the potential causal relationships between abnormal cervical fascial tension and craniocerebral as well as ocular pathology. It bears emphasizing that the above cross-level causal chain is currently based on literature-derived inference; the functional connections between each level await subsequent computational simulation, histological, and human studies for stepwise validation. This hypothesis remains to be further tested by empirical research.

21 October 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
Xuefeng HuangXuefeng Huang
Xuefeng Huang
Background: Increased neck circumference is commonly viewed as a simple surrogate marker of upper-body adiposity and cardiometabolic risk. However, cervical fat accumulation simultaneously alters the mechanical load borne by the investing fascia, and reduced elastic buffering capacity may permit abnormal shear stress to be conducted through the deep cervical fascial network to the carotid sheath. The carotid sheath is an anatomical hub shared by the internal carotid artery, internal jugular vein, lymphatic vessels, glymphatic outflow pathways, cervical sympathetic trunk, and vagus nerve.Objective: To organize evidence from anatomical, epidemiological, imaging, and intervention studies within a testable integrative framework, to grade evidence maturity by node, and to propose a research agenda.Methods: This narrative review evaluates the “six-system coupling framework” as a testable integrative perspective rather than an established causal mechanism. Evidence maturity was graded by node using a custom five-tier scale. The core empirical gap was identified as the absence of simultaneous measurement of investing fascia elasticity, intra-sheath pressure, and intra-sheath functional markers in the same individual.Results: Anatomically, the investing fascia and the carotid sheath have a composite relationship that is partly loose and partly directly continuous. Focal absence and midline-crossing connections further increase the spatial heterogeneity of transmission, whereas the prevertebral fascia serves as an anatomical barrier and protective mechanical constraint around the sheath. Evidence is strongest at the arterial node, supported by longitudinal cohorts, vascular-bed specificity, and PIEZO1/2 molecular candidates, and is graded moderate-high. The venous node has human evidence of mechanical sensitivity but has not been replicated under fascial mechanical exposure, and is graded moderate-low. The autonomic node has human muscle sympathetic nerve activity (MSNA) associations and randomized controlled trial (RCT) evidence for heart rate variability (HRV), but the intervention was not neck-specific, and is graded moderate. The glymphatic node has only indirect human associations and animal mechanistic evidence, and is graded low.Conclusions: Neck circumference and fascial mechanical parameters should be incorporated into multisystem rehabilitation assessment and monitored as mediators linking superficial body load to deep structural function. For rehabilitation, entry-level weight reduction and effector-level autonomic modulation can serve as independent components; investing fascia-targeted interventions at the transmission-interface level are currently investigational only. Their status as an independent intervention target awaits clarification through longitudinal studies oriented toward mediation analysis and functional endpoints.

21 October 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
Xuefeng HuangXuefeng Huang
Xuefeng Huang
Background: Buffalo hump is often oversimplified as localized fat accumulation, but its tissue composition is heterogeneous, and its clinical significance extends beyond cosmetic concerns. Neck circumference has accumulated relatively consistent evidence in cardiometabolic epidemiology, but most integrated analyses have used metabolic risk factors or metabolic syndrome as endpoints rather than hard endpoints such as stroke. Whether enlargement of the buffalo hump leads to an increase in neck circumference, and whether interventions that reduce the buffalo hump or neck circumference can translate into stroke prevention, remain unresolved. This narrative review examines the evidence linking buffalo hump and neck circumference to stroke risk and identifies structural gaps that currently preclude translation into prevention strategies.Methods: PubMed, Embase, the Cochrane Library, and the China National Knowledge Infrastructure were searched through March 2026 using terms for buffalo hump or dorsocervical fat, neck circumference, stroke or carotid atherosclerosis, and physical therapy or exercise. Population studies, intervention studies, mechanistic studies, and systematic reviews/meta-analyses reporting neck circumference, buffalo hump, carotid imaging, or stroke/cardiovascular endpoints were included. Case reports alone, narrative reviews without quantitative outcomes, and duplicate publications were excluded. After deduplication, title/abstract screening, and full-text assessment, 42 articles were included. As a narrative review, screening was performed by a single author without independent dual screening; selection bias cannot be excluded, and exhaustive retrieval according to systematic review standards is not claimed. Results: Buffalo hump is morphologically heterogeneous and frequently co-occurs with obesity and metabolic disorders. Increased neck circumference is associated with ischemic stroke and its subclinical precursor, independently of overall obesity. In a cohort of 3,009 patients with type 2 diabetes, high neck circumference was associated with an approximately 2.3-fold higher risk of a composite cardiovascular endpoint that included stroke; this estimate was not stroke-specific. The association was relatively robust in women in some East Asian cohorts; however, a cohort using the same cutoffs reported stronger predictive performance in men, and negative results from the Jackson Heart Study and the Framingham Offspring Cohort indicate that the direction and presence of the association are not uniform across populations. Pericarotid fat density and perivascular adipose tissue attenuation show incremental predictive signals beyond plaque burden in some studies, but this incremental value has not been consistently quantified, and their quantitative relationship with neck circumference has not been established. Surgical debulking, diet, physical therapy, and exercise have preliminary evidence, but none has reported postintervention neck circumference change in relation to stroke endpoints. Forward head posture remains an untested candidate pathway. Conclusions: The existing evidence supports treating buffalo hump and neck circumference as surface markers of stroke risk and potential intermediate targets, but it is still insufficient to support the clinical conclusion that treating or reducing buffalo hump, or lowering neck circumference, can prevent stroke. Concurrent collection of neck circumference, buffalo hump subtype, carotid imaging parameters, obstructive sleep apnea (OSA) severity, atrial fibrillation, forward head posture parameters, and stroke endpoints, together with systematic tracking of postintervention neck circumference trajectories, may translate the current descriptive associations into testable prevention hypotheses.

29 October 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
Xuefeng HuangXuefeng Huang
Xuefeng Huang
The clinical association between internal jugular vein (IJV) outflow obstruction and symptoms such as headache, pulsatile tinnitus, and cognitive decline has been repeatedly observed; however, “venous compression” alone is insufficient to explain the marked clinical heterogeneity of the condition. Among 283 patients with nonthrombotic IJV stenosis, the prevalence of headache was 65.02%; however, within the framework of this hypothesis, risk depends more on whether collateral compensatory capacity (and concurrent valvular antireflux function) is adequate than on the anatomical severity of stenosis—severe vertebral vein dilation, as a marker of adequate collateral compensation, was independently inversely associated with headache risk (OR = 0.184, 95% CI 0.092–0.366). Clinical consequences depend more on whether collateral compensation and valvular function remain sufficient to maintain outflow after compression. This hypothesis attributes this difference to whether compensation is adequate when IJV outflow is obstructed and proposes its upstream factor: sclerotic fibrosis of the investing fascia. Core proposition: Fibrosis of the investing fascia, through loss of elastic buffering and transmission of abnormal mechanical stress via the deep cervical fascial network to the carotid sheath, reduces collateral compensatory capacity when IJV outflow is obstructed and may coexist with insufficient valvular antireflux function; this state of inadequate compensation—centered on collateral compensation with valvular function as a parallel dimension—rather than luminal stenosis itself, is the key mediator linking extrasheath fascial pathology to fluctuating elevation of intracranial venous pressure. This framework provides a unified upstream mechanical perspective for understanding diseases and clinical phenotypes that share a common component of venous outflow obstruction, including headache associated with IJV stenosis, pulsatile tinnitus and cerebral tinnitus, exertional headache, Ménière disease, transient monocular blindness, insomnia, autonomic dysfunction, anxiety/depression/brain fog, vertigo, facial pain, and Eagle jugular syndrome. The hypothesis predicts that investing fascial stiffness is independently associated with compensatory indicators during IJV outflow obstruction; collateral compensatory capacity modifies the association between investing fascial fibrosis and symptoms; and relief of extrasheath mechanical constraint produces paired improvements in venous flow parameters and symptoms.

8 October 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
Xuefeng HuangXuefeng Huang
Xuefeng Huang
The core mechanism of epilepsy is generally summarized as abnormal synchronized neuronal firing. Although antiseizure medications, surgery, vagus nerve stimulation, and the ketogenic diet continue to improve, some patients continue to have drug-resistant epilepsy and often also have forward head posture, neck pain, insomnia, anxiety, autonomic dysfunction, and brain fog. These comorbidities are difficult to attribute entirely to epilepsy itself or to medication side effects, suggesting an underrecognized downstream amplification mechanism. Within the framework of investing fascia–carotid sheath–six-system coupling, this paper proposes a testable hypothesis: in some patients with epilepsy, fibrosis of the investing fascia and mechanical coupling of the carotid sheath may act as downstream amplifying factors and contribute to a reduced seizure threshold through impaired venous return, decreased glymphatic and meningeal lymphatic clearance, autonomic imbalance, sleep disruption, and neuroinflammation. Investing fascia release, through mechanical unloading, may reduce abnormal mechanical input, improve clearance and autonomic function, and thereby reverse this amplification process and raise the seizure threshold. Currently, there is no direct clinical evidence for this hypothesis, and it cannot replace standard treatment. Another subgroup hypothesis is that in patients with epilepsy who have objective evidence of altered blood supply, investing fascia release may improve blood supply and raise the seizure threshold; in those without such evidence, the effect may be less apparent. This paper is a theoretical derivation based solely on published literature and proposes testable predictions and a validation framework.

13 October 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
Xuefeng HuangXuefeng Huang
Xuefeng Huang
The deep cervical fascial system consists of three layers: the investing layer of the deep cervical fascia (investing fascia), the pretracheal fascia (middle layer), and the prevertebral fascia (deep layer). This hypothesis proposes that chronic forward head posture or sustained cervical stress may lead to fibrotic remodeling of the investing fascia, resulting in abnormally elevated passive tension. This abnormal tension may be transmitted indirectly to the carotid sheath region through the interwoven collagen fiber network among the layers of the deep cervical fascia, or through intermediate interfaces such as the visceral fascia, thereby contributing to fibrotic thickening of the sheath wall and surrounding tissues. Thickening of the posterior wall of the carotid sheath may exert sustained mechanical compression on the cervical sympathetic trunk immediately posterior to it, thereby causing sympathetic dysfunction and autonomic imbalance. It should be noted that the fascial composition of the carotid sheath remains controversial. The investing fascia and the sheath wall may not be directly fused; instead, they may be indirectly connected through intermediate interfaces such as the visceral fascia. Zhao et al. confirmed in a rabbit model that the carotid sheath has a three-layered fascial architecture: the inner fascial layer on the arterial side appears earliest and is the thickest, and the outer fascial layer shows potential fusion between adjacent structures, suggesting a possible spatial gradient in sheath wall thickening. However, that study was performed at a developmental stage and in an animal model, and it cannot directly prove that pathological fibrotic thickening causes compression of the sympathetic trunk. Lyons and Mills found during human cadaveric dissection that the cervical sympathetic trunk was located inside the carotid sheath in some individuals. Park et al. further integrated the anatomical features of the middle cervical ganglion through meta-analysis, and Salazar-Orellana et al. reported a clinical case in which venous dilation within the sheath compressed the sympathetic trunk and caused sympathetic overactivity. He et al. confirmed in a rat model that atlantoaxial misalignment can cause hypertension, and blood pressure decreased after removal of the implant. Cassaglia et al. confirmed in anesthetized lambs that mechanical elevation of blood pressure can directly increase sympathetic activity in the superior cervical ganglion, suggesting that the causal chain from upper cervical mechanical misalignment or an altered mechanical environment to sympathetic activation and elevated blood pressure is verifiable in animal models. Lee et al. reported a case in which scar formation after rhabdomyolysis of the longus colli and scalene muscles compressed and tethered the cervical sympathetic trunk, causing Horner syndrome, providing direct human clinical evidence for the pathway from cervical soft tissue pathological change to mechanical compression of the sympathetic trunk and sympathetic dysfunction. Okamoto et al. and Farage et al. respectively reported cases of marked fibrosis around the carotid artery and inflammatory pseudotumor of the carotid sheath, providing histological and imaging evidence that fibrosis can occur in the carotid sheath region. Langevin et al. used ultrasound to confirm that fascial thickness and echogenicity increased by approximately 25% in patients with chronic low back pain, providing a methodological precedent for ultrasound quantification of pathological fascial thickening. If this mechano-neural coupling pathway holds true, it may contribute to the peripheral drive of distal pathological conditions such as cervicogenic hypertension, cerebral hypoperfusion, and ocular disorders. However, its core components have not yet been directly validated in animal or human models. This hypothesis is based on evidence from anatomy, histology, biomechanics, molecular biology, pathophysiology, and clinical research. It constructs an evidence integration framework spanning anatomical structure, histological basis, mechanical properties, molecular transduction, pathological experiments, physiological effects, human epidemiology, alternative mechanism controls, and interventional validation, and it proposes testable predictions and a validation framework. At the same time, this hypothesis incorporates negative control evidence and alternative mechanism evidence to define the boundary conditions of the effects of cervical sympathetic trunk intervention. Currently, no animal model or human study has directly simulated sympathetic trunk compression caused by fibrotic thickening of the carotid sheath wall. This is the main evidence gap of this hypothesis, rather than a gap in the literature.